Get more information about the current state of gout research.

Sign Up Now

Are Your Patients’ sUA Levels Low Enough?Various serum concentrations yield different results
REDUCTION OF
URATE
DEPOSITION ONGOING
URATE
DEPOSITION
  • 0 to 4.0
    mg/dL
  • 4.1 to 5.9
    mg/dL
  • 6.0 to 6.8
    mg/dL
  • >6.8
    mg/dL

Potential to resolve tophi and reduce the urate burden faster.1

Image of man standing

Begins to slowly dissolve visible and nonvisible tophi. Flares decrease in frequency.1,8

Image of man standing with his head down

Slows progression of gout; urate burden remains essentially unchanged. Flares can continue to occur.1,3,4

Image of man standing and rubbing his wrist

Urate continues to deposit in joints, tissues, and organs. Flares can increase in frequency.2,5,6

Image of man standing, rubbing his wrist, and grimacing

Find out if oral ULTs are
the right treatment option

LEARN MORE

sUA, serum uric acid; ULT, urate-lowering therapy.

References

  1. Perez-Ruiz F. Rheumatology (Oxford). 2009;48(suppl 2):ii9-ii14.
  2. Maiuolo J, et al. Int J Cardiol. 2016;213:8-14.
  3. Schumacher HR Jr, et al. Arthritis Rheum. 2008;59:1540-1548.
  4. FitzGerald JD, et al. Arthritis Care Res (Hoboken). 2020;72:744-760.
  5. Doghramji PP, et al. Postgrad Med. 2012;124:98-109.
  6. Vargas-Santos AB, et al. Am J Kidney Dis. 2017;70:422-439.
  7. Perez-Ruiz F, et al. Arthritis Rheum. 2002;47:610-613.
  8. Shoji A, et al. Arthritis Rheum. 2004;51(6):321-325.